Beta-blockade for mitral regurgitation: Could the management of valvular heart disease actually be moving into the 21st century?

Journal of the American College of Cardiology

Volumn 60, Issue 9, 2012, Pages 839-840

  Carabello, Blase A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

mitral regurgitation; valve disease

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; METOPROLOL; PLACEBO; TROPONIN;

ADRENERGIC ACTIVITY; CARDIOVASCULAR SYSTEM EXAMINATION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE VARIABILITY; HUMAN; MEDICAL ASSESSMENT; MITRAL VALVE REGURGITATION; NEUROLOGIC EXAMINATION; NONHUMAN; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR BLOCKING; TREATMENT OUTCOME;

EID: 84865307098     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.028     Document Type: Editorial

References (15)

1. R. Bonow, B.A. Carabello, C. Kanu ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease) J Am Coll Cardiol 48 2006 e1 e148
2. R. Rosenhek, F. Rader, U. Klaar Outcome of watchful waiting in asymptomatic severe mitral regurgitation Circulation 113 2006 2238 2244
3. P.A. Pellikka, M.E. Sarano, R.A. Nishimura Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up Circulation 111 2005 3290 3295 (Pubitemid 40875002)
4. 1 -receptor blockade for chronic degenerative mitral regurgitation J Am Coll Cardiol 60 2012 833 838
5. R.H.J. Mehta, M.A. Supiano, H. Oral Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation Am J Cardiol 85 2000 1193 1197
6. R.J. Mehta, M.A. Supiano, P.M. Grossman Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation Am Heart J 147 2004 729 735 (Pubitemid 38900468)
7. M. Nagatsu, M.R. Zile, H. Tsutsui Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function Circulation 89 1994 818 826 (Pubitemid 24056211)
8. H. Tsutsui, F.G. Spinale, M. Nagatsu Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation J Clin Invest 93 1994 2639 2648 (Pubitemid 24177182)
9. P. Varadarajan, N. Joshi, D. Appel, L. Duvvuri, R.G. Pai Effect of beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction Am J Cardiol 102 2008 611 615
10. Y. Nagatomo, B.A. Carabello, M.L. Coker Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control Am J Physiol Heart Circ Physiol 278 2000 H151 H161
11. D. Oceandy, R. Yusoff, F.M. Baudoin, L. Neyses, S.G. Ray Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodeling in mitral valve prolapsed patients Eur J Heart Fail 9 2007 1010 1017 (Pubitemid 47451810)
12. L. Ljungvall, M.M. Rajamaki, S. Crosara Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease Am J Vet Res 72 2011 1022 1028
13. Y. Urabe, D.L. Mann, R.L. Kent Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation Circ Res 70 1992 131 147
14. L.A. Mulieri, M.D. Tischler, B.J. Martin Regional differences in the force-frequency relation of human left ventricular myocardium in mitral regurgitation: implications for ventricular shape Am J Physiol Heart Circ Physiol 288 2005 H2185 H2191
15. L.A. Mulieri, B.J. Leavitt, B.J. Martin, J.R. Haeberle, N.R. Alpert Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin Circulation 88 1993 2700 2704 (Pubitemid 23360195)